Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
4,992,318
-
Total 13F shares
-
16,970,149
-
Share change
-
+16,970,149
-
Total reported value
-
$236,408,000
-
Price per share
-
$13.97
-
Number of holders
-
29
-
Value change
-
+$236,407,446
-
Number of buys
-
29
Institutional Holders of Mersana Therapeutics, Inc. - Common Stock, par value $0.0001 per share (MRSN) as of Q2 2017
As of 30 Jun 2017 Mersana Therapeutics, Inc. - Common Stock, par value $0.0001 per share (MRSN) had 29 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 16,970,149 shares of stock of the company.
Largest 10 holders included NEA Management Company, LLC, WELLINGTON MANAGEMENT GROUP LLP, FMR LLC, Rock Springs Capital Management LP, ProQuest Associates IV LLC, RHO CAPITAL PARTNERS INC, ArrowMark Colorado Holdings LLC, JPMORGAN CHASE & CO, SCOPIA CAPITAL MANAGEMENT LP, and Alyeska Investment Group, L.P..
This table shows 29 institutional shareholders of the security as of 30 Jun 2017.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.